Table 3.
Costs of treatment to the health-care system, 2017 US$
| Plasmodium falciparum (Pf) and mixed infections | Plasmodium vivax (Pv) or other species | |||||
|---|---|---|---|---|---|---|
| Details | Cost of drugs | Cost of care | Details | Cost of drugs | Cost of care | |
| Outpatient | DHAPIP | 4.12 | 6.71 | Chloroquine/primaquine | 0.41 | 4.29 |
| Additional costs in pregnancy | 3 days of DOTS | 0 | 13.83 | 3 days of DOTS | 0 | 13.83 |
| Inpatient | IVATS | 66.75 | 238.88 | IVATS + DHAPIP | 70.87 | 31.28 |
| Relapse | – | – | – | DHAPIP | 4.12 | 6.71 |
| Severe | IVATS + ATQ | 119.72 | 1,219.46 | IVATS + DHAPIP | 70.87 | 1,268.32 |
| Resistant | IVATS + ATQ | 119.72 | 1,219.46 | – | – | – |
ATQ = atovaquone–proguanil; DHAPIP = dihydroartemisinin–piperaquine; DOTS = directly observed treatment; IVATS = intravenous artesunate.